Recall Z-1430-2020— Normand-Info S.A.S.U.
Class II · Terminated
Class II FDA medical device recall by Normand-Info S.A.S.U., initiated 2019-08-15, terminated 2021-06-03. FDA's recall record names no specific 510(k) clearance for this event. Product: Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems. Reason: A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who successfully exploited this vulnerability could execute arbitrary code on the target system; then install programs; view, change, or delete data; or create new accounts with full user rights. If the vulnerability could be exploited locally, it would lock down the computer..
- Recalling firm
- Normand-Info S.A.S.U.
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2019-08-15
- Terminated
- 2021-06-03
- Firm location
- Arras CEDEX, N/A, France
Product description
Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems
Reason for recall
A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who successfully exploited this vulnerability could execute arbitrary code on the target system; then install programs; view, change, or delete data; or create new accounts with full user rights. If the vulnerability could be exploited locally, it would lock down the computer.
Data sourced from openFDA. This site is unofficial and independent of the FDA.